IL1B and diabetic retinopathy: Experimental studies have also showed that intravitreal administration of IL-1β increases vascular permeability, which appears to be mediated by leukocyte adhesion, nuclear factor kappa-B activation, and retinal capillary cell death [204, 211], suggesting that this inflammatory cytokine might also play an important role in the pathogenesis of diabetic retinopathy.